REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

Clinical trial NCT07015905 · RECRUITING

Trial details

NCT number: NCT07015905
Sponsor: Regeneron Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Venous Thromboembolism (VTE)

Start date: 2025-06-25
Primary completion: 2027-02-20
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.